Flexibility And Agility Key To Speedy UK COVID Vaccine Approval
MRHA Head Insists No Compromises Were Made In Review Of Pfizer/BioNTech Vaccine
The flexibility and agility of parallel teams of scientists and clinicians who worked around the clock were key to speedy UK approval of the COVID-19 vaccine, according to UK agency head June Raine. Canada has also just announced that it has approved the Pfizer/BioNTech vaccine.
